Loading...
Please wait, while we are loading the content...
Similar Documents
Ranibizumab in neovascular age-related macular degeneration
| Content Provider | Scilit |
|---|---|
| Author | Kertes, Peter J. |
| Copyright Year | 2006 |
| Description | Neovascular age-related macular degeneration (AMD) is a visually devastating condition resulting from choroidal neovascularization and secondary photoreceptor loss. Ranibizumab and bevacizumab are medications that target vascular endothelial growth factor (VEGF). While other therapies have demonstrated some ability to reduce the risk of losing vision from neovascular AMD, most patients continue to lose some degree of central visual acuity. There is growing evidence that intravitreal administration of ranibizumab and bevacizumab is effective in significantly improving the visual acuity in patients with neovascular age-related macular degeneration. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699647/pdf |
| Ending Page | 466 |
| Page Count | 16 |
| Starting Page | 451 |
| ISSN | 11769092 |
| e-ISSN | 11781998 |
| DOI | 10.2147/ciia.2006.1.4.451 |
| Journal | Clinical interventions in aging |
| Issue Number | 4 |
| Volume Number | 1 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2006-12-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Clinical Interventions in Aging Ophthalmology Age-related Macular Degeneration Choroidal Neovascularization Ranibizumab Bevacizumab |
| Content Type | Text |
| Resource Type | Article |
| Subject | Geriatrics and Gerontology |